期刊文献+

维A酸泡囊凝胶剂的体外透皮扩散试验 被引量:1

Study on transdermal diffusion of retinoic acid in niosomal gels in vitro
原文传递
导出
摘要 目的:研究自制维A酸泡囊凝胶剂的体外透皮扩散率及皮肤内的蓄积量。方法:以酸性异丙醇为溶剂,用分光光度法在波长352nm处测定维A酸,采用离体鼠皮透皮扩散试验方法,测定维A酸泡囊凝胶对小鼠皮透皮扩散率及皮外残留量,并以市售乳膏等作对照。结果:测定方法的回收率为(99.01±0.77)%,含量为标示量的98%~99%。泡囊凝胶的透皮扩散率和皮外残留量均显著低于乳膏(分别为P<0.005,P<0.001),在皮肤内蓄积量却显著高于乳膏(P<0.001)。结论:维A酸的测定方法可靠,其泡囊凝胶药物主要蓄积于皮肤内,利于提高对皮肤病的疗效和降低全身毒性。 OBJECTIVE To study the transdermal diffusion rate and the drug amount retained in skin of self-prepared retinoic acid niosomal gels in vitro. METHODS Retinoie acid was determined by spectrophotometry at 352 nm using acidic isopropyl alcohol as the solvent;and transdermal diffusion through mouse skin and drug residue on the skin were measured with retinoie acid gels and commercial retinoic acid cream as controls in vitro. RESULTS Mean recovery of the assay method was (99. 01 ± 0. 77) % and the drug content was 98% - 990% of the labeled amount. Transdermal diffusion rate and residual rate on the skin of the niosornal gels were significantly lower than those of the cream(P〈0. 005 and P〈0. 001 ),however, the niosotnal gels showed significantly higher drug amount retained in the skin(P〈0. 001). CONCLUSION The assay method was reliable,and the niosomal gels showed good capacity to retain drug in the skin, which indicates the niosomal gels might enhance therapeutic efficiency against skin diseases and reduce systemic adverse reaction.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第7期537-540,共4页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金资助项目(编号:30572262) 四川大学大学生创新实验计划项目(编号:2008104)
关键词 维A酸 泡囊凝胶 透皮扩散试验 皮肤内药物的蓄积量 retinoic acid niosomal gels transdermal diffusion test drug amount retained in the skin
  • 相关文献

参考文献7

  • 1陆彬.作为载药系统的聚合物胶束和泡囊的研究[J].河南大学学报(医学版),2008,27(1):1-7. 被引量:6
  • 2Njar VC, Gediya L, Purushottamachar P, et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases [J]. Bioorg Med Chem,2006,14 (13): 4323-4340.
  • 3Soo-Jeong Lima, Mi-Kyung Leeb, Chong-Kook Kim. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders [J]. J Control Re lease,2004,100 ( 1 ) :53-61.
  • 4杨红,陈华黎,刘赟赟,卓国清,赵晨,黄嘉兰.维A酸贴剂的体外透皮扩散研究[J].中国药师,2007,10(7):666-668. 被引量:3
  • 5Manconi M,Sinico C, Valenti D,et al. Niosomes as carriers for tretinoin. Ⅰ. Preparmion and properties [J]. Int J Pharm,2002, 234 (1 2):237-248.
  • 6卢进,杨红,牟家婉,魏大鹏,吴琼,李雪,程亚西,莫生宁.维A酸隐形泡囊的制备及其体外性质的研究[J].华西药学杂志,2009,24(3):238-240. 被引量:1
  • 7Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations [J]. Int J of Pharm,2004,270 (1-2):179-186.

二级参考文献48

共引文献7

同被引文献5

  • 1陈永,杨红,陆彬,李玫,宗太丽.肺靶向顺铂泡囊的研制与体外性质的评价[J].华西药学杂志,2008,23(2):129-132. 被引量:8
  • 2Sharon Levy, MD, Katharine Furst, et al. A pharnlacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in t)a tients with Actinic Keratosis [J]. Clin Ther, 2001, 23 (6):908-920.
  • 3Venuganti W, Perumal OP. Effect of poly (amidoamine) (PAMAM)dendrimer on skin permeation of 5- fluorouracil[J]. Int J Pharm, 2008, 361 : 230-238.
  • 4Balakrishnan P, Shanmugam S, l.ee WS, et al. Formul ation and in vitro assessment of minoxidil niosomes for enhanced skin delivery[J].Int J Pharm, 2009, 377: 1-8.
  • 5Alsarra IA, Bosela AA, Ahmed SM, et al. Proniosomes as a drug carrier for transdermal delivery of kelorolac[J].Eur .J Pharm Biopharm, 2005, 59:485- 490.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部